InsiderTrades

Form 4 for REGN Regeneron Pharmaceuticals

Accepted 2022-11-03 00:00:00 ET · period of report 2022-11-01 · accession 0001883850-22-000088 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-11-03 2022-11-01 REGN RYAN ARTHUR F Dir S - Sale $755.89 -100 19.4K -0.5% -$75.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-01 S D 10 $753.68 19,464 D — — (F3) Represents volume-weighted average price of sales of 10 shares of Company stock on November 1, 2022 at prices ranging from $753.23 to $753.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
2 Common Common Stock 2022-11-01 S D 12 $754.73 19,452 D — — (F4) Represents volume-weighted average price of sales of 12 shares of Company stock on November 1, 2022 at prices ranging from $754.06 to $754.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
3 Common Common Stock 2022-11-01 S D 18 $755.50 19,434 D — — (F5) Represents volume-weighted average price of sales of 18 shares of Company stock on November 1, 2022 at prices ranging from $755.11 to $755.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
4 Common Common Stock 2022-11-01 S D 15 $757.58 19,393 D — — (F7) Represents volume-weighted average price of sales of 15 shares of Company stock on November 1, 2022 at prices ranging from $757.00 to $757.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
5 Common Common Stock 2022-11-01 S D 4 $758.16 19,389 D — — (F8) Represents volume-weighted average price of sales of 4 shares of Company stock on November 1, 2022 at prices ranging from $758.05 to $758.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
6 Common Common Stock 2022-11-01 S D 5 $759.61 19,384 D — — (F9) Represents volume-weighted average price of sales of 5 shares of Company stock on November 1, 2022 at prices ranging from $759.00 to $759.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
7 Common Common Stock 2022-11-01 S D 2 $761.00 19,382 D — —
8 Common Common Stock 2022-11-01 S D 6 $752.59 19,474 D — — (F2) Represents volume-weighted average price of sales of 6 shares of Company stock on November 1, 2022 at prices ranging from $752.28 to $752.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
9 Common Common Stock 2022-11-01 S D 2 $750.00 19,480 D — —
10 Common Common Stock 2022-11-01 S D 26 $756.31 19,408 D — — (F6) Represents volume-weighted average price of sales of 26 shares of Company stock on November 1, 2022 at prices ranging from $756.01 to $756.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.